Location History:
- Sodertalje, SE (2017)
- Macclesfield, GB (2012 - 2019)
Company Filing History:
3 out of 1,500 
2 out of 329 
2 out of 789 
Years Active: 2012-2019
Title: Christopher John Squire: Innovator in Chemical Processes
Introduction
Christopher John Squire is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemical processes, particularly in the synthesis of quinazoline derivatives. With a total of 6 patents to his name, Squire's work has implications in pharmaceutical applications.
Latest Patents
One of Squire's latest patents involves a chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline. This invention relates to the manufacture of certain quinazoline derivatives and their pharmaceutically acceptable salts. The patent also covers processes for producing intermediates that are useful in the manufacture of these quinazoline derivatives. In particular, it focuses on the chemical processes and intermediates that facilitate the production of the compound mentioned.
Career Highlights
Throughout his career, Christopher John Squire has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Array Biopharma. His experience in these organizations has contributed to his expertise in chemical processes and innovation.
Collaborations
Squire has collaborated with notable professionals in his field, including Jorgen Blixt and Michael David Golden. These collaborations have likely enriched his research and development efforts.
Conclusion
Christopher John Squire stands out as an influential inventor in the realm of chemical processes, with a focus on quinazoline derivatives. His contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to innovation and advancement in chemical synthesis.